Cysteamine suppresses invasion, metastasis and prolongs survival by inhibiting matrix metalloproteinases in a mouse model of human pancreatic cancer.
BACKGROUND: Cysteamine, an anti-oxidant aminothiol, is the treatment of choice for nephropathic cystinosis, a rare lysosomal storage disease. Cysteamine is a chemo-sensitization and radioprotection agent and its antitumor effects have been investigated in various tumor cell lines and chemical induce...
Main Authors: | Toshio Fujisawa, Benjamin Rubin, Akiko Suzuki, Prabhudas S Patel, William A Gahl, Bharat H Joshi, Raj K Puri |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3332081?pdf=render |
Similar Items
-
Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer
by: Puri Raj K, et al.
Published: (2011-04-01) -
Expression of matrix metalloproteinase 9 in pancreatic ductal carcinoma is associated with tumor metastasis formation.
by: Andrzej Kemona, et al.
Published: (2007-03-01) -
Behavioral and Neurochemical Responses to Cysteamine Administration in Mice: An Evaluation of Cysteamine as a Potential Antidepressant
by: Chu-Hsin Shieh, et al.
Published: (2007) -
A monoclinic polymorph of cysteamine hydrochloride
by: Saeed Ahmad, et al.
Published: (2010-01-01) -
Synthesis and evaluation of novel cysteamine prodrugs
by: Cardwell, W. A.
Published: (2006)